K-numberK242936
Device namePowder Free Nitrile Examination Gloves (Blue, Black), Tested for Use with Chemotherapy Drugs and Fentanyl Citrate
ApplicantSunray Medical Products, Inc.
Product codeLZA
Device classClass I
Decision dateJan 15, 2025
DecisionSubstantially Equivalent
Regulation880.6250
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

Powder-free nitrile examination gloves in blue and black colors, designed for medical purposes to prevent contamination between patient and examiner. The gloves are single-use, disposable, non-sterile, and have been tested for chemical permeation resistance to multiple chemotherapy drugs (including cisplatin, cyclophosphamide, doxorubicin, fluorouracil, methotrexate, paclitaxel, etoposide, and dacarbazine) and fentanyl citrate, with a warning against use with carmustine and thiotepa due to very low breakthrough times.

Technological characteristics

Both subject and predicate devices are powder-free, nitrile, ambidextrous examination gloves with beaded cuffs and Class I classification. Subject device adds XXL size (predicate offers XS-XL) and includes blue/black colors (predicate was purple). Physical specifications are identical: finger and palm thickness of 0.05mm minimum, tensile strength of 14 MPa before and after aging, elongation of 500% before and 400% after aging, and freedom from holes at G-I AQL 2.5. Subject device supports 3-year shelf life while predicate shelf life was not stated.

Test standards cited

ASTM D6319-19 (nitrile glove specifications), ASTM D5151-19 (glove hole detection), ASTM D6124-06 (powder residue), ASTM D412-16 (tensile properties), ASTM D6978-05 (chemotherapy drug permeation), ISO 10993-5 (cytotoxicity), ISO 10993-10 (skin sensitization), ISO 10993-11 (acute systemic toxicity), and ISO 10993-23 (skin irritation).

Substantial equivalence argument

The subject device meets identical physical and performance specifications to the predicate across all measured parameters (dimensions, tensile strength, elongation, hole resistance, powder residue). Biocompatibility testing produces equivalent results. Chemical permeation performance against tested chemotherapy drugs and fentanyl citrate is substantially similar, with minor variations in breakthrough times for carmustine and thiotepa that are clinically managed by clear labeling warnings against use with those drugs. The addition of XXL size and different colors do not alter the fundamental function or safety profile, as evidenced by passing all performance and biocompatibility requirements.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →